Dan Janney - Profile and Investment Details

Investor Profile

Dan Janney is a Venture Capital, Investor based in United States with a diverse investment portfolio that includes companies such as Lassen Therapeutics, Avid Radiopharmaceuticals, Nereus Pharmaceuticals, Calistoga Pharmaceuticals, Chimerix, Sutro Biopharma, Larimar Therapeutics, Aegis Semiconductor, Esperion Therapeutics, Taligen Therapeutics, Coapt Systems, Tyra Biosciences, GenePeeks, DispatchHealth, ChemoCentryx, Sunesis Pharmaceuticals, Intradigm Corporation, SurgRx, PneumRx, PatientsLikeMe, Cara Therapeutics, Immune Design, Sonexa Therapeutics, Trevena, Excaliard Pharmaceuticals, Xelerated, MacroGenics, St. George's University, SARcode Bioscience, Neothetics, Kite Pharma, Sierra Surgical, VertiFlex, Virobay, CymaBay Therapeutics, Allakos, ImmuneID, EGenesis, ZS Pharma, Everside Health, Portola Pharmaceuticals, TransMedics, Aegerion Pharmaceuticals, Vir Biotechnology, Esperion, Pathwork Diagnostics, MAKO Surgical, CuraSen Therapeutics, DEM BioPharma, Aerovance, Achaogen, Evofem Biosciences, Aerie Pharmaceuticals, Be Biopharma, Anesiva, Kiadis Pharma, Carbylan Therapeutics, Applied Genetics Technologies Corporation, Variant Bio, Lumena Pharmaceuticals, Corcept Therapeutics, aTyr Pharma, Foldrx Pharmaceuticals, 7TM Pharma, Novome Biotechnologies, Qihan Biotech. Over time, Dan Janney has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Dan Janney is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Genetics, Women Founded, Life Science, Information Services, Biotech, Medical Device, Software, Healthcare, Biotechnology, Genomics, Home Care, Medical, Therapeutics, mHealth, Pharmaceuticals, Biopharma may find it worthwhile to explore potential connections with Dan Janney, as their portfolio suggests a familiarity and interest in this area.

Understanding Dan Janney’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.